ZENITHDRUG
Start SIP
Invest Now
Start SIP in ZENITHDRUG
Performance
- Low
- ₹58
- High
- ₹60
- 52 Week Low
- ₹47
- 52 Week High
- ₹107
- Open Price₹58
- Previous Close₹60
- Volume10,400
Investment Returns
- Over 1 Month -2.47%
- Over 3 Month -7.78%
- Over 6 Month -25.41%
- Over 1 Year -40.13%
Smart Investing Starts Here Start SIP with Zenith Drugs for Steady Growth!
Zenith Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.2
- PEG Ratio
- -
- Market Cap Cr
- 102
- P/B Ratio
- 1.6
- Average True Range
- 3.16
- EPS
- 4.26
- Dividend Yield
- 0
- MACD Signal
- -1.11
- RSI
- 41.72
- MFI
- 46.85
Zenith Drugs Financials
Zenith Drugs Technicals
EMA & SMA
Current Price
₹59.30
-0.9
(-1.5%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹62.15
- 50 Day
- ₹64.38
- 100 Day
- ₹67.28
- 200 Day
- ₹71.32
Resistance and Support
59.25
- R3 62.95
- R2 61.70
- R1 60.50
- S1 58.05
- S2 56.80
- S3 55.60
Zenith Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-05-29 | Audited Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-04-17 | To consider Fund Raising & Others | To consider Other business matters. (Revised) Final Dividend of Re. 0.5 per equity share |
| 2024-11-14 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Zenith Drugs F&O
About Zenith Drugs
- NSE Symbol
- ZENITHDRUG
- BSE Symbol
- Managing Director
- Mr. Sandeep Bhardwaj
- ISIN
- INE0QWN01013
Similar Stocks to Zenith Drugs
Zenith Drugs FAQs
Zenith Drugs share price is ₹59 As on 15 November, 2025 | 15:03
The Market Cap of Zenith Drugs is ₹101.7 Cr As on 15 November, 2025 | 15:03
The P/E ratio of Zenith Drugs is 14.2 As on 15 November, 2025 | 15:03
The PB ratio of Zenith Drugs is 1.6 As on 15 November, 2025 | 15:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.